Anxiolytics (Milestones in Drug Therapy)

ISBN 13: 9783034895811

Anxiolytics (Milestones in Drug Therapy)

0 avg rating
( 0 ratings by Goodreads )
 
9783034895811: Anxiolytics (Milestones in Drug Therapy)
View all copies of this ISBN edition:
 
 

For over thirty years the benzodiazepines monopolised not only the anxiolytic market but also clinical and animal research in anxiety. Indeed many animal tests developed since the 1960s have been optimised for the benzodiazepines and some programmes have even screened candidates as potential anxiolytics on their benzodiazepine-like side-effects rather than their anxiolytic activity. With the realisation of the drawbacks of the benzodiazepines, namely their potential for tolerance and dependency, there has been a renewed interest in alternative anxiolytics both from existing drugs such as the tricyclic and monoamine oxidase antidepressants and from newer agents such as buspirone. In addition anxiety is no longer considered to be a unique entity but rather an umbrella term for a series of specific anxiety disorders such as panic disorder without or with agoraphobia, generalised anxiety disorder (GAD), specific phobias, social phobias and post-traumatic stress disorder (PTSD). These new clinical categories have opened another dimension in the therapy of anxiety requiring the optimisation of treatments for different syndromes. This book is a critical review of today's anxiolytics and those that may become the anxiolytics of tomorrow. What is clear is that currently there are few clinically satisfactory alternatives to the benzodiazepines for the treatment of acute anxiety. For chronic anxiety, it is generally agreed that benzodi­ azepines are not the treatment of first choice. The tricyclic and monoamine oxidase antidepressants, the serotonin reuptake inhibitors and buspirone offer better solutions for chronic anxiety but they are still far from being ideal.

"synopsis" may belong to another edition of this title.

Other Popular Editions of the Same Title

9783764360320: Anxiolytics (Milestones in Drug Therapy)

Featured Edition

ISBN 10:  3764360321 ISBN 13:  9783764360320
Publisher: Birkhäuser, 2000
Hardcover

Top Search Results from the AbeBooks Marketplace

1.

ISBN 10: 303489581X ISBN 13: 9783034895811
New Quantity Available: 5
Seller:
ReadWhiz
(Portland, OR, U.S.A.)
Rating
[?]

Book Description Condition: New. Seller Inventory # ria9783034895811_ing

More information about this seller | Contact this seller

Buy New
US$ 173.47
Convert currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, rates & speeds

2.

MIKE BRILEY
Published by Birkhäuser (2012)
ISBN 10: 303489581X ISBN 13: 9783034895811
New Paperback Quantity Available: 1
Seller:
Herb Tandree Philosophy Books
(Stroud, GLOS, United Kingdom)
Rating
[?]

Book Description Birkhäuser, 2012. Paperback. Condition: NEW. 9783034895811 This listing is a new book, a title currently in-print which we order directly and immediately from the publisher. For all enquiries, please contact Herb Tandree Philosophy Books directly - customer service is our primary goal. Seller Inventory # HTANDREE0416182

More information about this seller | Contact this seller

Buy New
US$ 164.11
Convert currency

Add to Basket

Shipping: US$ 10.53
From United Kingdom to U.S.A.
Destination, rates & speeds

3.

Published by Birkhäuser (2000)
ISBN 10: 303489581X ISBN 13: 9783034895811
New Softcover Quantity Available: 15
Print on Demand
Seller:
Rating
[?]

Book Description Birkhäuser, 2000. Condition: New. This item is printed on demand for shipment within 3 working days. Seller Inventory # LP9783034895811

More information about this seller | Contact this seller

Buy New
US$ 182.75
Convert currency

Add to Basket

Shipping: US$ 3.21
From Germany to U.S.A.
Destination, rates & speeds

4.

Mike Briley
Published by Springer Basel (2012)
ISBN 10: 303489581X ISBN 13: 9783034895811
New Quantity Available: > 20
Print on Demand
Seller:
Pbshop
(Wood Dale, IL, U.S.A.)
Rating
[?]

Book Description Springer Basel, 2012. PAP. Condition: New. New Book. Shipped from US within 10 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # IQ-9783034895811

More information about this seller | Contact this seller

Buy New
US$ 202.77
Convert currency

Add to Basket

Shipping: US$ 3.99
Within U.S.A.
Destination, rates & speeds

5.

Mike Briley
Published by Birkh?user (2012)
ISBN 10: 303489581X ISBN 13: 9783034895811
New Quantity Available: > 20
Print on Demand
Seller:
Books2Anywhere
(Fairford, GLOS, United Kingdom)
Rating
[?]

Book Description Birkh?user, 2012. PAP. Condition: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # IQ-9783034895811

More information about this seller | Contact this seller

Buy New
US$ 215.20
Convert currency

Add to Basket

Shipping: US$ 11.85
From United Kingdom to U.S.A.
Destination, rates & speeds

6.

Briley, Mike
Published by Birkhäuser (2016)
ISBN 10: 303489581X ISBN 13: 9783034895811
New Paperback Quantity Available: 1
Print on Demand
Seller:
Ria Christie Collections
(Uxbridge, United Kingdom)
Rating
[?]

Book Description Birkhäuser, 2016. Paperback. Condition: New. PRINT ON DEMAND Book; New; Publication Year 2016; Not Signed; Fast Shipping from the UK. No. book. Seller Inventory # ria9783034895811_lsuk

More information about this seller | Contact this seller

Buy New
US$ 225.69
Convert currency

Add to Basket

Shipping: US$ 5.10
From United Kingdom to U.S.A.
Destination, rates & speeds

7.

Published by Springer Basel, Switzerland (2012)
ISBN 10: 303489581X ISBN 13: 9783034895811
New Paperback Quantity Available: 10
Seller:
The Book Depository EURO
(London, United Kingdom)
Rating
[?]

Book Description Springer Basel, Switzerland, 2012. Paperback. Condition: New. Language: English. Brand new Book. For over thirty years the benzodiazepines monopolised not only the anxiolytic market but also clinical and animal research in anxiety. Indeed many animal tests developed since the 1960s have been optimised for the benzodiazepines and some programmes have even screened candidates as potential anxiolytics on their benzodiazepine-like side-effects rather than their anxiolytic activity. With the realisation of the drawbacks of the benzodiazepines, namely their potential for tolerance and dependency, there has been a renewed interest in alternative anxiolytics both from existing drugs such as the tricyclic and monoamine oxidase antidepressants and from newer agents such as buspirone. In addition anxiety is no longer considered to be a unique entity but rather an umbrella term for a series of specific anxiety disorders such as panic disorder without or with agoraphobia, generalised anxiety disorder (GAD), specific phobias, social phobias and post-traumatic stress disorder (PTSD). These new clinical categories have opened another dimension in the therapy of anxiety requiring the optimisation of treatments for different syndromes. This book is a critical review of today's anxiolytics and those that may become the anxiolytics of tomorrow. What is clear is that currently there are few clinically satisfactory alternatives to the benzodiazepines for the treatment of acute anxiety. For chronic anxiety, it is generally agreed that benzodi- azepines are not the treatment of first choice. The tricyclic and monoamine oxidase antidepressants, the serotonin reuptake inhibitors and buspirone offer better solutions for chronic anxiety but they are still far from being ideal. Softcover reprint of the original 1st ed. 2000. Seller Inventory # APC9783034895811

More information about this seller | Contact this seller

Buy New
US$ 265.79
Convert currency

Add to Basket

Shipping: US$ 3.95
From United Kingdom to U.S.A.
Destination, rates & speeds